Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Africa. The aim of this observational study is to evaluate the
incidence of adverse events while using NovoMix® 30 FlexPen® under normal clinical practice
conditions.